Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Societal CDMO
Societal CDMO
Activities:
Manufacturing
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
Societal CDMO expands manufacturing to address expanding psychedelic market
Societal CDMO has announced an expansion of its controlled substance manufacturing capabilities to address expanding psychedelic drug development market
Manufacturing
Societal CDMO wins tech transfer and production contract for HIV drug candidate
The small molecule CDMO has been selected to provide services to support the ongoing clinical development of a novel drug candidate in Europe
Manufacturing
Societal CDMO unveils new "20/80" tech transfer service model
The pharmaceutical CDMO has developed a service model to provide time- and cost-efficient preparedness strategy for mitigating supply chain risks and vulnerabilities
Subscribe now